Search
Inborn Errors of Bile Acid Synthesis
go.drugbank.com/conditions/DBCOND0046673Drugs: Cholic AcidSynonyms: Inborn error in primary bile acid synthesisSulfamethoxazole
go.drugbank.com/drugs/DB01015ApprovedInvestigationalin the biosynthesis of nucleic acids and proteins which are necessary for bacterial growth and division, and using them in conjunction helps to slow the development of bacterial resistance. … [L11830] In this combination, sulfamethoxazole is useful for the treatment of a variety of bacterial infections, including those of the urinary, respiratory, and gastrointestinal tracts.
Mixtures: COMAZOLE N TABLET, KEMOPRİM FORT 800/160 TABLETCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseLambert Eaton Myasthenic Syndrome (LEMS)
go.drugbank.com/conditions/DBCOND0053084Drugs: AmifampridineSynonyms: Lambert-Eaton syndrome in neoplastic diseaseNirsevimab
go.drugbank.com/drugs/DB16258ApprovedInvestigational[L44146] Nirsevimab was also approved by Health Canada on April 19, 2023 and by the FDA in July 17, 2023 for the same indication.[L46392,L47461] … [A254571,L44146] On November 2022, nirsevimab was approved by the EMA for the prevention of RSV lower respiratory tract disease in newborns and infants.
Categories: Antiinfectives for Systemic UseTazobactam
go.drugbank.com/drugs/DB01606ApprovedInvestigationalIt is combined with [Piperacillin] and [Ceftolozane] for the treatment of a variety of bacterial infections. … Piperacillin-tazobactam was initially approved by the FDA in 1994, and ceftolozane-tazobactam was approved by the FDA in 2014[FDA label], providing wider antibacterial coverage for gram-negative infections
Mixtures: Zosyn in Galaxy Containers, Zosyn in Galaxy ContainersCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseHypromellose
go.drugbank.com/drugs/DB11075ApprovedInvestigationalIt is a commonly used as a delivery component in oral pharmaceutical products that provides the release of a drug in a controlled fashion, effectively increasing the duration of release of a drug to prolong … Hypromellose, or hydroxypropyl methylcellulose (HPMC) [L1812], is a semisynthetic, inert, and viscoelastic polymer that forms a colloid solution when dissolved in water.
Mixtures: Rohto All-In-One, Visine for Dry Eye True TearsCategories: Compounds used in a research, industrial, or household settingStrontium chloride
go.drugbank.com/drugs/DB13987ApprovedWithdrawnSuch strontium chloride toothpaste formulations may subsequently not be available for sale anymore in certain parts of the world [A33167, A33168]. … Strontium chloride (SrCl2) is a salt of strontium and chloride.
Sickle Cell Disease
go.drugbank.com/conditions/DBCOND0029334Synonyms: Double heterozygous for Hb S and Hb D, Hereditary hemoglobinopathy disorder homozygous for hemoglobin SChronic Myelomonocytic Leukemia
go.drugbank.com/conditions/DBCOND0028572Synonyms: Chronic myelomonocytic leukemia in transformation [obs], Chronic myelomonocytic leukaemia in transformation [obs]Garetosmab
go.drugbank.com/drugs/DB16379ApprovedInvestigational[L63940,L64047] It is the second therapy approved for FOP, following [palovarotene] (Sohonos), which was approved in 2023, and is the first FOP therapy shown to reduce clinician-assessed flare-ups. … [L63940] Garetosmab-grts was approved by the FDA on August 19, 2026 to reduce the number of new heterotopic ossification lesions and clinician-assessed flare-ups in adults with FOP.